Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Mayo Clinic Laboratories, |
RCV001507586 | SCV001713217 | uncertain significance | not provided | 2020-11-12 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002359138 | SCV002658012 | uncertain significance | Cardiovascular phenotype | 2020-03-18 | criteria provided, single submitter | clinical testing | The p.W20317C variant (also known as c.60951G>C), located in coding exon 157 of the TTN gene, results from a G to C substitution at nucleotide position 60951. The tryptophan at codon 20317 is replaced by cysteine, an amino acid with highly dissimilar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |